Literature DB >> 13629114

Treatment with cortisone of haemorrhagic disease due to a circulating anticoagulant.

W M HENDERSON.   

Abstract

Entities:  

Keywords:  CORTISONE/therapeutic use; HEMORRHAGIC DIATHESIS/therapy

Mesh：

Substances：

Year:  1959        PMID： 13629114      PMCID： PMC1993005          DOI： 10.1136/bmj.1.5124.764

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  Haemorrhagic diathesis due to a circulating anticoagulant investigated by the thromboplastin generation test.

Authors:  D M EVANS
Journal:  J Clin Pathol       Date:  1955-05       Impact factor: 3.411

2.  Immunization of rabbits against human anti-hemophilic factor (AHF).

Authors:  M D RICHARDS; T H SPAET
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

3.  Occurrence and mode of action of endogenous circulating anticoagulants.

Authors:  J VANDENBROUCKE; M VERSTRAETE
Journal:  J Lab Clin Med       Date:  1956-11

4.  Acquired haemophilia-like disease; report of a case with studies on the mode of action of the circulating anticoagulant.

Authors:  R M HARDISTY
Journal:  J Clin Pathol       Date:  1954-02       Impact factor: 3.411

5.  Haemophilia-like syndrome from anticoagulants affecting the production of thromboplastin.

Authors:  I S COLLINS; D G FERRIMAN
Journal:  Lancet       Date:  1952-10-11       Impact factor: 79.321

6.  Measurement of thromboplastic factors and profactors in plasma. I. Deficits in thromboplastin; study of reagents; measurements of antihemophilic and of platelet activities.

Authors:  J P SOULIER; M J LARRIEU
Journal:  J Lab Clin Med       Date:  1953-06

7.  Pseudo-haemophilia: an acquired haemorrhagic diathesis due to a circulating anticoagulant.

Authors:  C HOUGIE
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

8.  Hemophilia-like disease following pregnancy with transplacental transfer of an acquired circulating anticoagulant.

Authors:  P G FRICK
Journal:  Blood       Date:  1953-07       Impact factor: 22.113

9.  Researches on a circulating anticoagulant in a hemophiliac.

Authors:  S VAN CREVELD; P G HOORWEG; M M P PAULSSEN
Journal:  Blood       Date:  1953-02       Impact factor: 22.113

10.  Refractoriness in hemophilia to coagulation-promoting agents: whole blood and plasma derivatives.

Authors:  W B FROMMEYER; R D EPSTEIN; F H L TAYLOR
Journal:  Blood       Date:  1950-05       Impact factor: 22.113
  10 in total
  1 in total

1.  A CIRCULATING ANTICOAGULANT INHIBITING ANTIHAEMOPHILIC GLOBULIN.

Authors:  P H PINKERTON; J H DAGG; F TAYLOR
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.